CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Open platformOpen platform

Veracyte’s Decipher Test Predicts Abiraterone Benefit in Very High-Risk Prostate Cancer Study

By Public Technologies
  • Veracyte’s Decipher Prostate test predicted benefit from adding abiraterone to hormone therapy in men with very high-risk, nonmetastatic prostate cancer.
  • The retrospective analysis of the Phase III STAMPEDE trial included 401 patients; higher Decipher scores identified greater benefit in reducing cancer spread.
  • Findings support using the test before treatment intensification to weigh potential benefits against abiraterone’s added side effects and treatment burden.
  • Results will be presented at the European Society for Medical Oncology Congress on October 24, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veracyte Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610230400PRIMZONEFULLFEED9851884) on October 23, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk